ASIX vs CMT

Key Takeaways

• AdvanSix (ASIX) is an integrated chemistry company with a diversified product portfolio spanning nylon, plant nutrients, and chemical intermediates, generating approximately $1.52 billion in annual sales.
• Core Molding Technologies (CMT) is a niche engineered materials company specializing in molded structural products, with annual sales of roughly $274 million and a strong push into new end markets.
• Both companies faced revenue headwinds in their core segments during recent quarters, but each has demonstrated margin resilience and strategic discipline through cost management.
• ASIX offers a competitive dividend yield near 3%, while CMT trades at a considerably lower price-to-earnings (P/E) multiple and carries significantly less debt relative to earnings.
• Market sentiment around each stock reflects different risk profiles: ASIX is tied to agricultural and industrial chemical cycles, while CMT is navigating a known customer transition and betting on multi-year growth investments.

Introduction

Comparing ASIX and CMT presents an instructive contrast between two small-cap industrial manufacturers operating in entirely different segments of the U.S. economy. AdvanSix produces essential chemicals used in fertilizers, plastics, and industrial solvents. Core Molding Technologies manufactures engineered composite and plastic structural components for trucks, powersports vehicles, and building products. This stock comparison is particularly relevant for investors evaluating the trade-offs between a cyclical commodity-linked business with a dividend and a niche manufacturer investing aggressively for growth. While neither company dominates headlines, both represent the kind of specialized industrial names that can offer asymmetric opportunities when market conditions shift in their favor.

ASIX Overview and Recent Performance

AdvanSix Inc. (ASIX) is a diversified chemistry company headquartered in Parsippany, New Jersey, that manufactures nylon resin, caprolactam (a precursor to nylon), ammonium sulfate fertilizers, and chemical intermediates including acetone and phenol. The company serves a broad range of end markets including agriculture, automotive, construction, and packaging. With a market capitalization of approximately $546 million and trailing twelve-month revenue of roughly $1.52 billion, AdvanSix operates at the intersection of agricultural and industrial chemical supply chains.

In recent weeks, ASIX shares have traded in the $19 to $21 range, well off their 52-week high of $26.73 but notably above the 52-week low of $14.10. The stock has exhibited higher-than-market volatility with a beta of 1.30. Full-year 2025 results reflected a mixed operating environment: total sales were essentially flat year over year at $1.52 billion, while net income of $49.3 million and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $156.8 million both improved from the prior year. The company's Plant Nutrients segment — now its largest at 37% of sales — has benefited from favorable North American ammonium sulfate supply and demand conditions, while the Nylon Solutions business continues to navigate an extended cyclical trough. Management has responded with a multi-year fixed cost savings program targeting approximately $30 million in annual savings, alongside a significant reduction in planned capital expenditures (capex) from roughly $116 million in 2025 to a projected $75–$95 million in 2026, signaling a sharper focus on free cash flow generation.

CMT Overview and Recent Performance

Core Molding Technologies Inc. (CMT), headquartered in Columbus, Ohio, is a specialized engineered materials company that manufactures molded thermoplastic and thermoset structural products. Its processes — including sheet molding compound (SMC) compression molding, direct long-fiber thermoplastic (DLFT) molding, and resin transfer molding (RTM) — serve the medium and heavy-duty truck, powersports, building products, and industrial markets across the United States, Canada, and Mexico. With a market capitalization near $208 million and annual sales of approximately $274 million, CMT operates at a significantly smaller scale than ASIX.

CMT shares have recently traded around $24, positioned roughly in the middle of their 52-week range of $16.37 to $28.69. The stock carries a notably low beta of 0.43, reflecting lower volatility relative to the broader market. Full-year 2025 revenue declined approximately 9.5% to $273.8 million, primarily due to weakness in the truck sector — which still represents roughly 44% of product sales — and the planned phase-out of a major customer program known as the Volvo transition. Despite the top-line pressure, gross margins held within management's targeted 17%–19% range, and the company generated $19.2 million in operating cash flow. A standout development has been the company's aggressive diversification push: CMT secured $63 million in new business wins during 2025, with over 65% of those wins outside the traditional truck and powersports segments. The company is also investing approximately $25 million in Mexican plant expansions — including a greenfield facility in Monterrey — to support multi-year programs expected to deliver $150 million in incremental revenue, with management projecting a path to over $300 million in total revenue by 2027.

Trending AI Robots

Tickeron's Trending AI Robots page is a curated showcase of the platform's most compelling AI-powered trading agents, selected from among hundreds of available bots that trade thousands of different tickers across equities, ETFs, and other instruments. Each robot operates on a unique combination of trading style, strategy, time horizon, and technical framework — ranging from ultra-short 5-minute breakout agents to 60-minute swing-trading systems. Performance metrics vary widely: top-performing bots have posted annualized returns exceeding 100%, with win rates reaching above 65% and profit factors as high as 4.53, meaning $4.53 earned for every dollar risked. The Trending section highlights only those bots most aligned with prevailing market dynamics, helping traders cut through the noise and identify strategies suited to current conditions. Explore the full selection at Trending AI Robots to see which automated strategies are capturing opportunity in today's markets.

Head-to-Head Comparison

The most striking difference between these two companies lies in their business models and revenue scale. ASIX operates in high-volume commodity chemical markets where pricing is largely dictated by global supply-demand balances, raw material costs (benzene, propylene, natural gas, sulfur), and agricultural cycles. Its revenue base is roughly 5.5 times larger than CMT's, providing greater absolute operating leverage but also deeper exposure to cyclical swings. CMT, by contrast, operates a customer-driven engineered products business where long-term program wins, operational execution, and customer concentration risk shape outcomes more than commodity prices.

On valuation, the divergence is pronounced. ASIX trades at a trailing P/E (price-to-earnings) ratio above 50, reflecting depressed near-term earnings relative to its share price, while CMT trades at a trailing P/E near 22 — a substantially lower multiple. However, ASIX returns capital to shareholders through a dividend yielding roughly 3%, whereas CMT pays no dividend and instead deploys capital toward organic growth investments and share repurchases. Balance sheet strength also differentiates the two: CMT carries a debt-to-EBITDA ratio under 1x with total liquidity of approximately $88 million, while ASIX carries higher leverage but is actively reducing capex to improve free cash flow.

Risk profiles diverge as well. ASIX faces ongoing uncertainty in the nylon cycle and exposure to volatile raw material inputs, partially offset by strength in Plant Nutrients and tax credit tailwinds from its 45Q carbon capture program. CMT faces customer concentration risk — a single truck OEM transition explains a large share of recent revenue declines — but is actively mitigating that through diversification and new facility investments that should begin contributing more meaningfully in the second half of 2026 and into 2027.

Tickeron AI Verdict

Based on observable trend consistency, relative valuation, balance sheet quality, and forward-looking catalysts, Tickeron's AI-driven analysis would likely tilt toward CMT in the current environment, though with measured conviction. The rationale centers on several factors: CMT demonstrates more consistent gross margin stability within its stated range despite declining volumes, carries a considerably lower valuation multiple, maintains a debt-to-EBITDA ratio below 1x, and has tangible multi-year growth catalysts in the form of $63 million in new program wins and a clearly articulated path toward $300 million in revenue by 2027. Additionally, CMT's lower beta of 0.43 suggests it has been less susceptible to broad market drawdowns — a factor AI models often weight favorably during periods of macroeconomic uncertainty. That said, ASIX is not without its own merit: its Plant Nutrients strength, cost-savings initiatives, reduced capex trajectory, and dividend yield create a compelling value-recovery narrative should the nylon cycle trough and chemical intermediates pricing stabilize. In probabilistic terms, CMT currently presents a cleaner combination of manageable risk and identifiable growth, while ASIX may become the more attractive candidate if agricultural markets remain robust and industrial chemical demand accelerates. Neither stock is without risk, and both warrant ongoing monitoring as market conditions evolve.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations